Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CrossAmerica Partners (CAPL) Asset Writedowns and Impairment (2016 - 2024)

Historic Asset Writedowns and Impairment for CrossAmerica Partners (CAPL) over the last 13 years, with Q4 2024 value amounting to $76000.0.

  • CrossAmerica Partners' Asset Writedowns and Impairment rose 243333.33% to $76000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $79000.0, marking a year-over-year increase of 9750.0%. This contributed to the annual value of $157000.0 for FY2024, which is 29250.0% up from last year.
  • Latest data reveals that CrossAmerica Partners reported Asset Writedowns and Impairment of $76000.0 as of Q4 2024, which was up 243333.33% from $3000.0 recorded in Q4 2023.
  • Over the past 5 years, CrossAmerica Partners' Asset Writedowns and Impairment peaked at $536000.0 during Q2 2020, and registered a low of $1000.0 during Q2 2021.
  • In the last 5 years, CrossAmerica Partners' Asset Writedowns and Impairment had a median value of $51000.0 in 2022 and averaged $120733.3.
  • In the last 5 years, CrossAmerica Partners' Asset Writedowns and Impairment plummeted by 9981.34% in 2021 and then soared by 420000.0% in 2022.
  • Quarter analysis of 5 years shows CrossAmerica Partners' Asset Writedowns and Impairment stood at $196000.0 in 2020, then dropped by 6.63% to $183000.0 in 2021, then tumbled by 49.18% to $93000.0 in 2022, then plummeted by 96.77% to $3000.0 in 2023, then surged by 2433.33% to $76000.0 in 2024.
  • Its Asset Writedowns and Impairment was $76000.0 in Q4 2024, compared to $3000.0 in Q4 2023 and $37000.0 in Q1 2023.